Westchester Capital Management (New York)’s CERo Therapeutics Warrants CEROW Stock Holding History

Westchester Capital Management (New York)’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-74,998	Closed	-$997	–	315
2025 Q3	$997	Hold	74,998	–	–	﹤0.01%	258
2025 Q2	$1.57K	Hold	74,998	–	–	﹤0.01%	210
2025 Q1	$937	Hold	74,998	–	–	﹤0.01%	172
2024 Q4	$622	Hold	74,998	–	–	﹤0.01%	166
2024 Q3	$383	Hold	74,998	–	–	﹤0.01%	191
2024 Q2	$1.5K	Hold	74,998	–	–	﹤0.01%	219
2024 Q1	$6.67K	Hold	74,998	–	–	﹤0.01%	224
2023 Q4	$1.88K	Hold	74,998	–	–	﹤0.01%	261
2023 Q3	$5.37K	Hold	74,998	–	–	﹤0.01%	283
2023 Q2	$4.58K	Hold	74,998	–	–	﹤0.01%	300
2023 Q1	$3.75K	Hold	74,998	–	–	﹤0.01%	340
2022 Q4	$2.95K	Buy	+74,998	New	+$3.94K	﹤0.01%	419

Other funds holding CEROW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Westchester Capital Management (New York)'s CEROW Position: Q4 2025 in Review

Westchester Capital Management (New York) sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 74,998 shares — an estimated $997 sold.

Westchester Capital Management (New York) first reported a position in CEROW in Q4 2022 and held it in 12 quarters. The position peaked at $6.67K in Q1 2024. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

Westchester Capital Management (New York) reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
Westchester Capital Management (New York) sold 74,998 CERo Therapeutics Warrants shares in Q4 2025, an estimated $997.
Westchester Capital Management (New York) first reported a position in CERo Therapeutics Warrants in Q4 2022 and held it in 12 quarters.
Westchester Capital Management (New York)'s CERo Therapeutics Warrants position peaked at $6.67K in Q1 2024.
1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.